Although the current study focused on the ATGL-mediated mechanisms as one of PKA-downstream pathways, we do not exclude the possibility that other PKA-downstream targets contribute to the anti-obesity effects of SEE. The gene discussed is PNPLA2; the disease is obesity disorder.